Summary by Moomoo AI
Brii Biosciences Limited will hold its Annual General Meeting on June 25, 2024 via Superior Electronic Conferencing System to discuss issues including adoption of audited consolidated financial statements, re-election of retiring directors, renewal of auditors, general mandates to issue and repurchase shares, etc. The Company has issued a circular to shareholders on 26 April 2024, accompanied by a proxy form. If shareholders are unable to attend, the proxy form must be submitted by 23 June 2024. In addition, the Company will suspend the registration of shares from 20 to 25 June 2024 in order to determine attendance and voting eligibility. All resolutions of the Annual General Meeting will be voted on by vote.